NFKB1 and cancer: Given the paramount importance of the NF-κB pathway not only in cancer development and chemotherapy resistance (55, –57) but also in receptor-mediated innate and adaptive immune responses (e.g., TNFα, interleukin-1, and interferons), our mechanistic findings based on studying genotoxic response will likely be generalized to canonical NF-κB signaling.